Immune electron microscopy

NanoImaging Services Appoints John Rigg as Chief Executive Officer

Retrieved on: 
Monday, January 8, 2024
LNP, Protein, Immune electron microscopy, Liverpool John Moores University, Biotechnology, Drug development, QA/QC, Ventria Bioscience, Quality control, SAN, Eli Lilly and Company, Nanoparticle, Growth, General partnership

SAN DIEGO, Jan. 8, 2024 /PRNewswire/ -- NanoImaging Services ("NIS"), the leading provider of cryo-electron microscopy ("cryo-EM") services to the pharmaceutical and biotechnology communities, announced today the appointment of John Rigg as Chief Executive Officer (CEO).

Key Points: 
  • SAN DIEGO, Jan. 8, 2024 /PRNewswire/ -- NanoImaging Services ("NIS"), the leading provider of cryo-electron microscopy ("cryo-EM") services to the pharmaceutical and biotechnology communities, announced today the appointment of John Rigg as Chief Executive Officer (CEO).
  • Brian Conkle, who served as interim CEO in 2023, will remain at NIS as Chief Operating Officer.
  • Mr. Rigg brings over 20 years of leadership experience within the pharmaceutical and biomanufacturing industries to NIS.
  • Most recently, he served as Chief Executive Officer of Exelead Biopharma, a biopharmaceutical contract development and manufacturing organization specializing in complex injectable formulations, including lipid nanoparticle (LNP) based drug delivery.

New York Structural Biology Center and Syncell Announce Partnership for Microscopy-Guided Proteomics

Retrieved on: 
Thursday, August 31, 2023
Health, Clinical Trials, General Health, Pharmaceutical, Optical, Biotechnology, Partnership, NMR, Proteomics, Proteome, Left, Multimedia, Research, Cell, Mass spectrometry, Immune electron microscopy, Protein, Center of excellence, Microscope

The New York Structural Biology Center (NYSBC), a global leading institute in structural biology, and Syncell, a life science tools company pioneering the technology of microscopy-guided proteomics discovery, are pleased to announce a partnership to create the Optoproteomics Center of Excellence, part of the new NYSBC Proteomics Core that includes Syncell’s Microscoop platform.

Key Points: 
  • The New York Structural Biology Center (NYSBC), a global leading institute in structural biology, and Syncell, a life science tools company pioneering the technology of microscopy-guided proteomics discovery, are pleased to announce a partnership to create the Optoproteomics Center of Excellence, part of the new NYSBC Proteomics Core that includes Syncell’s Microscoop platform.
  • “It is exciting to create a unique bridge between structural biology and proteomics at the NYSBC,” says Alex de Marco, Director of the Simons Electron Microscopy Center at the NYSBC.
  • The structural biology of protein complexes can then be further explored with NYSBC’s excellent NMR and cryoEM instrumentation and outstanding technical capacity in structural biology.
  • “It is exciting to introduce Syncell’s first global Center of Excellence at the NYSBC,” says Jung-Chi Liao, Founder and CEO of Syncell.

NanoImaging Services Receives Growth Equity Investment from Ampersand Capital Partners

Retrieved on: 
Monday, June 12, 2023
Science, Biotechnology, Drug discovery, West Pharmaceutical Services, Growth, NIS, Immune electron microscopy, Drug development, General partnership, QA/QC, SAN, Ampersand

SAN DIEGO, June 12, 2023 /PRNewswire/ -- NanoImaging Services ("NIS"), the leading provider of cryo-electron microscopy ("cryo-EM") services to the pharmaceutical and biotechnology communities, announced today that it has received a growth equity investment from Ampersand Capital Partners.

Key Points: 
  • SAN DIEGO, June 12, 2023 /PRNewswire/ -- NanoImaging Services ("NIS"), the leading provider of cryo-electron microscopy ("cryo-EM") services to the pharmaceutical and biotechnology communities, announced today that it has received a growth equity investment from Ampersand Capital Partners.
  • The company will use this investment to support its worldwide growth initiatives, including expanding microscope capacity and adding complementary services to further serve the needs of existing and future customers.
  • Peter Glick, Chairman of NIS, commented, "We are thrilled to have Ampersand joining NanoImaging Services as an investor and on the Board.
  • David Parker, General Partner at Ampersand Capital Partners who has joined NIS's Board, added, "NanoImaging Services is an excellent fit with Ampersand's strategy of partnering with specialized pharmaceutical services providers that have established leadership positions in attractive market segments based on differentiated science, strong technical expertise, and high service quality.

Scanning Electron Microscopes Market to be Worth $6.5 Billion by 2028: Grand View Research, Inc.

Retrieved on: 
Wednesday, October 12, 2022
SAN, Revenue, Thermo Fisher Scientific, Sale, Medicine, Prevalence, Growth, Science, NIS, Laboratory, Infection, CAGR, Immune electron microscopy, Biotechnology, 3D, Research, TEM, Partnership, Technology, Transmission electron microscopy, SEMS, Car, Conditional sentence, SEM, Nanotechnology, COVID-19, USD, ZEISS, Semiconductor, Microscope

SAN FRANCISCO, Oct. 12, 2022 /PRNewswire/ -- The global scanning electron microscopes market size is expected to reach USD 6.5 billion by 2028, registering a CAGR of 8.52% over the forecast period, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, Oct. 12, 2022 /PRNewswire/ -- The global scanning electron microscopes market size is expected to reach USD 6.5 billion by 2028, registering a CAGR of 8.52% over the forecast period, according to a new report by Grand View Research, Inc.
  • Rising demand for nanotechnology-based research and growing R&D innovation in application areas are anticipated to serve as key growth drivers.
  • Due to the growing prevalence of communicable diseases, the market is expected to observe substantial growth over the coming years.
  • Grand View Research has segmented the global scanning electron microscopes market on the basis of application and region:
    Scanning Electron Microscope Market - Application Outlook (Revenue, USD Million, 2016 - 2028)

Scanning Electron Microscopes Market to be Worth $6.5 Billion by 2028: Grand View Research, Inc.

Retrieved on: 
Wednesday, October 12, 2022
SAN, Revenue, Thermo Fisher Scientific, Sale, Medicine, Prevalence, Growth, Science, NIS, Laboratory, Infection, CAGR, Immune electron microscopy, Biotechnology, 3D, Research, TEM, Partnership, Technology, Transmission electron microscopy, SEMS, Car, Conditional sentence, SEM, Nanotechnology, COVID-19, USD, ZEISS, Semiconductor, Microscope

SAN FRANCISCO, Oct. 12, 2022 /PRNewswire/ -- The global scanning electron microscopes market size is expected to reach USD 6.5 billion by 2028, registering a CAGR of 8.52% over the forecast period, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, Oct. 12, 2022 /PRNewswire/ -- The global scanning electron microscopes market size is expected to reach USD 6.5 billion by 2028, registering a CAGR of 8.52% over the forecast period, according to a new report by Grand View Research, Inc.
  • Rising demand for nanotechnology-based research and growing R&D innovation in application areas are anticipated to serve as key growth drivers.
  • Due to the growing prevalence of communicable diseases, the market is expected to observe substantial growth over the coming years.
  • Grand View Research has segmented the global scanning electron microscopes market on the basis of application and region:
    Scanning Electron Microscope Market - Application Outlook (Revenue, USD Million, 2016 - 2028)

DGAP-News: The HealthTech For Care Innovation Award will be presented for the first time at the HealthTech Innovation Days on October 13 and 14, 2022 in Paris

Retrieved on: 
Tuesday, September 6, 2022
Lists of people executed in the United States, Sofinnova, McDermott Will & Emery, BNP Paribas, NSL, Association of British HealthTech Industries, Patient, Bristol Myers Squibb, Microsoft, HTFC, Ipsen, Communication, International Organization for Migration (IOM) Mission in Ukraine, Rothschild, Solution, Stifel, Amgen, China Investment Securities, France Biotech, Digital, Health, Weapon, Pharmaceutical industry, Biotechnology, Ferring, Immune electron microscopy, Euronext, Medtech, Organon

The HealthTech For Care Innovation Award will be presented for the first time at the HealthTech Innovation Days on October 13 and 14, 2022 in Paris

Key Points: 
  • The HealthTech For Care Innovation Award will be presented for the first time at the HealthTech Innovation Days on October 13 and 14, 2022 in Paris
    The issuer is solely responsible for the content of this announcement.
  • Paris, September 6, 2022, the HealthTech Innovation Days (HTID) event, organized by the HealthTech For Care (HTFC) endowment fund, is launching for the first time a pitch competition for European healthcare companies committed to patients.
  • The purpose is to offer these companies the opportunity to present their solutions to healthcare experts and investors.
  • The winner will receive the "HealthTech For Care innovation award, which goes along with privileged connections with HTFC sponsors, visibility through dedicated communication and free access to the 5th edition of the HealthTech Innovation Days (HTID) event.

DGAP-News: PROGRAMME OF THE 4th EDITION OF THE HEALTHTECH INNOVATION DAYS ON 13 & 14 OCTOBER 2022 IN PARIS

Retrieved on: 
Tuesday, July 12, 2022
Table, Biotechnology, Health, Royal commission, Health care, Patient, Union, Diagnosis, China Investment Securities, RNA transfection, Investor, Quality of life, NSL, BNP Paribas, Artificial intelligence, McDermott Will & Emery, Microsoft, Environment, Digitalization, Intelligence, Life expectancy, Place de la Bourse, Rothschild, Goal, European Commission, Solution, The, Ipsen, Rothschild & Co, Laboratory, Sofinnova, Amgen, Growth, Genomics, Heart, Association of British HealthTech Industries, France Biotech, Research, Bristol Myers Squibb, Pharmaceutical industry, Medical device, Hospital, Euronext, Ferring, Immune electron microscopy, EU

The 4th edition will take place in Paris, at The HealthTech Space , 16 place de la Bourse, 75002 Paris, and virtually (hybrid format).

Key Points: 
  • The 4th edition will take place in Paris, at The HealthTech Space , 16 place de la Bourse, 75002 Paris, and virtually (hybrid format).
  • The programme of the round tables of this 4th edition* is built around six major themes:
    European nations share common goals in terms of improving quality of life and increasing life expectancy.
  • The 4th edition will take place on October 13 and 14, 2022 under a hybrid format, combining in-person presentations, panels and one-on-one meetings in Paris with a virtual platform.
  • The HealthTech Innovation Days are sponsored by international pharmaceutical companies, other health innovation companies, investors and many international opinion leaders.

Institute for Bioscience and Biotechnology Research Receives $16.8 M Investment from the National Institute of Standards and Technology

Retrieved on: 
Thursday, January 13, 2022
Doctor of Philosophy, Provost, Research, State, Drug discovery, Vaccine, Immune electron microscopy, Biotechnology, College Park, University, FACS, COVID19, University of Maryland Center for Environmental Science, Foundation, MBA, Medical Affairs Bureau, National Institute of Standards and Technology, Solution, Government, National Institute, Cancer, History of the University of Maryland, College Park, Pandemic, Health, Maryland Board of Public Works, Maryland School, University of Maryland School of Medicine, Virginia BioTechnology Research Park, Non-governmental organization, University system, Biomedical Research, NIST, Dean, Engineering, List of life sciences, UMB, Senior, Institute, Pharmaceutical industry, Medical device, Management, MD, Technology

ROCKVILLE, Md., Jan. 13, 2022 /PRNewswire/ -- The Institute for Bioscience and Biotechnology Research (IBBR) announces a newly funded five-year cooperative agreement with the National Institute of Standards and Technology (NIST) headed by the Co-Directors of IBBR, Dr. David J. Weber (PI) and Dr. John Marino (NIST).

Key Points: 
  • ROCKVILLE, Md., Jan. 13, 2022 /PRNewswire/ -- The Institute for Bioscience and Biotechnology Research (IBBR) announces a newly funded five-year cooperative agreement with the National Institute of Standards and Technology (NIST) headed by the Co-Directors of IBBR, Dr. David J. Weber (PI) and Dr. John Marino (NIST).
  • IBBR is a joint research enterprise of the University of Maryland, College Park, the University of Maryland, Baltimore and NIST.
  • "UMB has invested heavily in operational support and high-end instruments for IBBR in support of the NIST relationship.
  • IBBR is a joint research enterprise of the University of Maryland, College Park, the University of Maryland, Baltimore, and the National Institute of Standards and Technology (NIST).

Ultra-clean biomedical nanofiber production now available from Nanoscience Instruments

Retrieved on: 
Thursday, December 16, 2021
Electrospinning, FDA, Immune electron microscopy, Gaps, HEPA, Microscopy, Doctor of Philosophy, Small Business Saturday, Industry, Solvent, Heating, ventilation, and air conditioning, Quartz, Temperature, CGMP, TEM, Paediatric-use marketing authorisation, Workflow, SEM, Sterilization, Medical device, Wood drying

PHOENIX, Dec. 16, 2021 /PRNewswire-PRWeb/ -- Nanoscience Instruments introduces the new biomedical Fluidnatek electrospinning systems into the US Market.

Key Points: 
  • PHOENIX, Dec. 16, 2021 /PRNewswire-PRWeb/ -- Nanoscience Instruments introduces the new biomedical Fluidnatek electrospinning systems into the US Market.
  • Nanoscience Instruments Application scientist Francisco J. Chaparro, PhD, has worked extensively with electrospinning systems, from home-built units, to premium, industrial grade systems.
  • Nanoscience Instruments is a trusted supplier of the most innovative and highest quality analytical solutions to academia and industry.
  • The full portfolio is available on the Nanoscience Instruments website: https://www.nanoscience.com/products/

Unrivaled 2 nanometer resolution tabletop Field-Emission Scanning Electron Microscope

Retrieved on: 
Thursday, October 28, 2021
Elemental, Acceleration, TEM, Lighthouse of Alexandria, Industry, Workflow, EDS, Software, Quartz, Acquisition, KV, Doctor of Philosophy, Immune electron microscopy, Microscopy, SEM, Microscope

The Pharos G2 also features the new Phenom user interface, which brings data acquisition and beautiful images into one widescreen display for intuitive navigation and control.

Key Points: 
  • The Pharos G2 also features the new Phenom user interface, which brings data acquisition and beautiful images into one widescreen display for intuitive navigation and control.
  • "The Phenom Pharos G2 system sets a new standard for FE-SEM performance," explains Sebastian Kossek, PhD, co-CEO of Nanoscience Instruments.
  • With a resolution of 2.0 nm at 20kV, and a rapid workflow, the Pharos G2 delivers performance and throughput that surpass expectations."
  • The new internal hardware produces higher resolution and provides images with exceptional contrast and unparalleled clarity, even accommodating sensitive or difficult samples.